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In the determination of non-transferrin (Tf) -bound iron (NTBI) in
serum, Jacobs et al. [1] compared several methods, of which 5 were
based on the detection of iron using chelators (nitrilotriacetic acid
(NTA) and oxalate) and 1 involved the measurement of redox-active
iron using the bleomycinmethod in the same samples. Results showed
that themean serumNTBI level differedwidely (range, 0.12–4.32 μmol/l)
between methods and between samples (CV range, 49.3–391.3%). That
is, accurate determination of serum NTBI is difﬁcult. In the present
study, we examined potential inaccuracy of the method developed
by Gosriwatana et al. [2] using NTA and ultraﬁltration for serum
NTBI determination. A method of Gosriwatana et al. [2] in the
presence of unsaturated Tf is included the blocking of iron-binding
sites in Tf with tris-carbonatocobaltate trihydrate (Co complex).
NTBI is converted to the Fe–NTA complex and is separated from
serum proteins by ultraﬁltration using a centrifugal device, Amicon®
Centricon-30 (30 kDa, Merck Millipore). Kolb et al. [3] have claimed
that the use of 80 mmol/l NTA (Gosriwatana et al. [2], Sasaki et al.
[4]) removes iron from Tf. Sasaki et al. [4] have improved the method
of Gosriwatana et al. [2] using reagents with a low level of iron
contamination and a new centrifugal device, Amicon® Ultra-0.5
(30 kDa, Merck Millipore).
Appropriate concentrations of iron citrate complex solutions (adjust
to pH 7) as a model of NTBI were prepared by mixing (molar ratio; Fe
1: citrate 1, Fe 1: citrate 2) the iron standard solution (0.01 mg Fe/ml in
2 mmol/l HNO3) with citric acid. To serum samples with 50–70% saturat-
ed Tf, Ga (GaCl3, pH3) or Co complex [2] solutionswere added as blockers
(0.9 mmol/l in reaction mixture) of unsaturated Tf. The samples were
then incubated for 1 h at 37 °C. After adding 2-[4-(2-hydroxylethyl)-1-
piperazinyl]ethanesulfonic acid (HEPES, pH 7.4) buffer solution and an
iron standard solution, Tf-bound iron (t Fe) in the serummixturewas an-
alyzed by high-performance liquid immunoafﬁnity chromatography
(HPLAC) [5]. As a result, the percentages of blocked vacant sites of Tf
were 8–10% (Ga) and 25–35% (Co complex). Moreover, in the presence
of 50% saturated Tf in the serum sample without blockers, iron citrate
complex was reacted with ‹10 mmol/l NTA, which did not affect the con-
tent of t Fe. This ﬁnding indicated that blockers of unsaturated Tf in serum
samples are not required. Using a serum sample with a high concentra-
tion (45 μmol/l) of iron and 70% saturated Tf, we examined the effect of
NTA (5–80 mmol/l) on iron removal from Tf. After adding NTA in0009-8981 © 2013 The Authors. Published by Elsevier B.V.
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Open access under CC BY-NC-ND liceHEPESor 2-morpholinopropane-1-sulfonic acid (MOPS, pH7.4) buffer so-
lution to the serum sample, the resulting mixture was incubated for
30min at room temperature, and t Fe in the serummixture was then an-
alyzed byHPLAC [5]. As a result, at ‹10mmol/l NTA, t Fewas not removed,
but 8% (3.6 μmol/l) of the t Fewas removedat 80mmol/l NTA. In addition,
it was found that the presence of 1mmol/l level of free desferrioxamine
and/or iron desferrioxamine complex did not affect the removal of t Fe.
After centrifugation (10,000g for 30 min at 4 °C) of the serum mixture
using Amicon® Ultra-0.5 (10–30 kDa) instead of Amicon® Centricon-30
(30 kDa), iron in the ultraﬁltrate was analyzed by graphite furnace
atomic absorption spectrometry (GFAAS) [6]. Only 25% (0.9 μmol/l) of
iron removed from Tf was recovered in the ultraﬁltrate. Consequently,
we examined whether the Fe–NTA complex is adsorbed onto the ultra-
ﬁltrationmembranes. Iron standard or iron citrate complex as the sam-
ple (9 μmol Fe/l) was reacted with NTA in HEPES or MOPS buffer
solution. Iron in the Fe–NTA solution before (as 100%) and after the
centrifugation was analyzed by GFAAS. As shown in Fig. 1, good recov-
ery (96–98%)was obtained, which did not depend on the concentration
of NTA. Serum ultraﬁltrate (protein-free) as a sample mediumwas pre-
pared from a normal adult serumwithout dilution by the ultraﬁltration
as described above.When the serum ultraﬁltrate was then added to the
Fe–NTA solution, poor recovery (40% of iron added at 80 mmol/l NTA
and 20% at 5 mmol/l NTA) was obtained (Fig. 1). It seems that the
protein-free low-molecular-weight substances in serum act as a binder
between the Fe–NTA complex and the ultraﬁltration membranes.
On the other hand, in the case of the method developed by Kolb et al.0
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Fig. 1. Adsorption of Fe–NTA complex onto ultraﬁltration membraneswithout (a) or with
(b) serum ultraﬁltrate.
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13Letter to the Editor[3], we found that serum proteins such us Tf passed through the ultra-
ﬁltration membranes (30 kDa) because of the use (4800g) of centrifu-
gal force beyond the limits (2000g) for the Centrifree® MPS-1 device
(#4010, Merck Millipore).
In conclusion, serum NTBI determination methods [2,4] using NTA
and the ultraﬁltration would lead to false positive error owing to t Fe re-
moval using a high concentration of NTA and false negative error owing
to the adsorption of the Fe–NTA complex onto ultraﬁltration mem-
branes. Thus, these methods are not promising for accurate NTBI
determination.References
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